Generated automatically from the NAFDAC register, WHO alerts and community data as of today. Not medical advice — always follow your doctor or pharmacist.
Add the expiry date printed on your pack for a full Trust Score — or look up uses, side effects and cheaper generics.
Apidra 100 IU/mL Solution for Injection in a Vial contains Insulin glulisine (1000 units/10 mL), as solution for injection, according to its NAFDAC registration record.
Yes. Apidra 100 IU/mL Solution for Injection in a Vial is listed on the NAFDAC register under registration number A6-0366, and its registration is active as of 6 November 2026.
No WHO falsified or substandard medical product alert currently matches Apidra 100 IU/mL Solution for Injection in a Vial in our automatically synced alert list.
Run a free authenticity scan with the NAFDAC number A6-0366, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.
Reviews are personal experiences from RxVerify users, not medical advice. Report side effects to your doctor and to NAFDAC.